- Conditions: Retinitis Pigmentosa; Choroideremia
Intervention: Device: Prototype wide view suprachoroidal retinal prosthesis
Sponsors: Center for Eye Research Australia; Center for Eye Research Australia
Recruiting - verified May 2012 - Conditions: Myocardial Infarction; Kidney Function
Intervention:
Sponsors: Monash University; Monash University
Recruiting - verified April 2012 - Condition: Heart Failure
Intervention:
Sponsors: Monash University; Monash University; National Health and Medical Research Council, Australia
Enrolling by invitation - verified April 2012 - Condition: Major Depressive Disorder
Intervention: Drug: Participants will be prescribed an approved selective serotonin re-uptake inhibitor (SSRI) antidepressant.
Sponsors: Baker IDI Heart and Diabetes Institute; Baker IDI Heart and Diabetes Institute; Alfred and Baker Medical Unit - Alfred Hospital; Monash Medical Centre - Southern Health; Ballarat Health Service Psychiatric Services
Not yet recruiting - verified March 2012 - Condition: Schizophrenia
Interventions: Drug: Moxonidine; Drug: Placebo; Drug: Moxonidine; Drug: Placebo
Sponsors: Baker IDI Heart and Diabetes Institute; Baker IDI Heart and Diabetes Institute; Alfred and Baker Medical Unit - Alfred Hospital; Monash Medical Centre - Southern Health; Ballarat Health Service Psychiatric Services
Not yet recruiting - verified April 2012 - Conditions: Greater Trochanteric Pain Syndrome; Hip Pain
Interventions: Device: Topaz; Procedure: Iliotibial band release and trochanteric bursectomy
Sponsors: ArthroCare Corporation; ArthroCare Corporation
Not yet recruiting - verified February 2012 - Condition: Heart Failure
Interventions: Drug: Withdrawal of statin therapy; Drug: Statin therapy
Sponsors: The Alfred; The Alfred
Recruiting - verified March 2012 - Condition: Heart Failure
Interventions: Drug: Aspirin; Other: withdrawal of aspirin
Sponsors: The Alfred; The Alfred
Not yet recruiting - verified February 2012 - Condition: Polycystic Ovary Syndrome
Interventions: Drug: Moxonidine; Drug: Placebo
Sponsors: Baker IDI Heart and Diabetes Institute; Baker IDI Heart and Diabetes Institute
Not yet recruiting - verified January 2012 - Conditions: Malignant Rectal Neoplasm; Recurrent Tumor
Intervention: Radiation: intraoperative radiotherapy
Sponsors: Peter MacCallum Cancer Centre, Australia; Peter MacCallum Cancer Centre, Australia
Completed - verified December 2011 - Condition: Coronary Artery Disease
Interventions: Procedure: High Flow oxygen; Procedure: Room Air
Sponsors: Bayside Health; Bayside Health
Not yet recruiting - verified December 2011 - Condition: Small Cell Lung Cancer
Intervention: Drug: Lithium
Sponsors: Barwon Health; Barwon Health; Victorian Cancer Agency
Not yet recruiting - verified December 2011 - Conditions: Major Depressive Disorder (MDD); Coronary Heart Disease (CHD); Cardiovascular Disease (CVD)
Interventions: Drug: Valdoxan (agomelatine); Drug: Lexapro (escitalopram)
Sponsors: Baker IDI Heart and Diabetes Institute; Baker IDI Heart and Diabetes Institute
Not yet recruiting - verified November 2011 - Conditions: Schizophrenia; Schizoaffective Disorder; Schizophreniform Disorder
Interventions: Drug: Raloxifene Hydrochloride; Drug: Placebo
Sponsors: The Alfred; The Alfred
Recruiting - verified January 2012 - Condition: Perimenopausal Depression
Intervention: Drug: Tibolone
Sponsors: The Alfred; The Alfred
Recruiting - verified January 2012 - Condition: Anaesthesia
Intervention: Other: Sedation depth
Sponsors: Melbourne Health; Melbourne Health
Recruiting - verified October 2011 - Condition: Abdominal Surgery
Interventions: Other: Liberal fluid therapy; Other: Restrictive fluid therapy
Sponsors: Bayside Health; Bayside Health; Australian and New Zealand College of Anaesthetists
Not yet recruiting - verified August 2011 - Condition: Appendicitis
Intervention: Drug: metronidazole and cephalzolin
Sponsors: Monash University; Monash University; Monash Medical Centre
Not yet recruiting - verified August 2011 - Condition: Ulcerative Colitis
Interventions: Drug: Rectal tactolimus; Drug: Placebo
Sponsors: The University of Western Australia; The University of Western Australia; Mater Health Services' Adult Hospital, Brisbane, Qld; Concord Hospital; The Canberra Hospital; Royal Prince Alfred Hospital, Sydney, Australia
Not yet recruiting - verified August 2011 - Condition: Chronic Obstructive Pulmonary Disease
Interventions: Behavioral: Home-based pulmonary rehabilitation; Behavioral: Hospital-based pulmonary rehabilitation
Sponsors: La Trobe University; La Trobe University; The Alfred; Austin Health; Monash University
Not yet recruiting - verified August 2011 - Condition: Heart Failure
Interventions: Drug: Withdrawal of digoxin; Drug: Digoxin
Sponsors: The Alfred; The Alfred
Recruiting - verified February 2012 - Conditions: Depressive Disorder; Depression
Intervention: Behavioral: Mood Memo emails
Sponsors: Orygen Youth Health Research Centre; Orygen Youth Health Research Centre; National Health and Medical Research Council, Australia; University of Melbourne; Sidney Myer Fund
Recruiting - verified November 2011 - Condition: Healthy Volunteers
Interventions: Drug: OZ439; Drug: OZ439 mesylate; Drug: OZ439 mesylate; Drug: OZ439
Sponsors: Medicines for Malaria Venture; Medicines for Malaria Venture; Nucleus Network Ltd; INC Research
Recruiting - verified April 2012 - Conditions: Prostate Cancer (Post Prostatectomy); Anal Cancer; Nasopharyngeal Cancer; Intermediate Risk Prostate Cancer
Intervention: Other: Non-Interventional Study
Sponsors: Trans-Tasman Radiation Oncology Group (TROG); Trans-Tasman Radiation Oncology Group (TROG)
Recruiting - verified June 2011 - Condition: Perimenopause Depression
Interventions: Drug: Tibolone; Drug: Escitalopram
Sponsors: The Alfred; The Alfred
Recruiting - verified January 2012 - Conditions: Abdominal Obesity; Hypertension
Interventions: Drug: Moxonidine; Drug: Irbesartan
Sponsors: Baker IDI Heart and Diabetes Institute; Baker IDI Heart and Diabetes Institute
Recruiting - verified February 2012 - Condition: Friedreich Ataxia
Intervention: Drug: Resveratrol
Sponsors: Murdoch Childrens Research Institute; Murdoch Childrens Research Institute; Friedreich Ataxia Research Alliance
Active, not recruiting - verified March 2012 - Condition: Acute Hepatitis C
Interventions: Drug: Peginterferon alfa-2a; Drug: Ribavirin
Sponsors: Kirby Institute; Kirby Institute
Not yet recruiting - verified April 2011 - Condition: Peripheral Arterial Disease
Interventions: Drug: Niacin/Laropiprant combination; Drug: Sugar pill
Sponsors: Bayside Health; Bayside Health; National Health and Medical Research Council, Australia
Recruiting - verified July 2011 - Condition: Breast Cancer
Interventions: Genetic: polymorphism analysis; Other: laboratory biomarker analysis; Procedure: quality-of-life assessment
Sponsors: International Breast Cancer Study Group; International Breast Cancer Study Group
Recruiting - verified March 2012 - Conditions: Cystic Fibrosis; Bronchiectasis
Interventions: Drug: Azithromycin; Drug: Placebo control
Sponsors: Queensland Children's Medical Research Institute; Queensland Children's Medical Research Institute; Telethon Institute for Child Heath Research
Enrolling by invitation - verified May 2012 - Conditions: Acute Myocardial Infarction; Coronary Artery Disease; Oxygen
Interventions: Other: Withholding oxygen in uncomplicated patients with STEMI; Other: Oxygen
Sponsors: Bayside Health; Bayside Health; Ambulance Victoria; Monash University - Department of epidemiology and preventitive medicine; Baker IDI Heart and Diabetes Institute; FALCK Foundation
Recruiting - verified October 2011 - Conditions: Depression; Major Depressive Disorder
Interventions: Drug: Oxytocin; Drug: Oxytocin and Tibolone; Drug: Placebo
Sponsors: The Alfred; The Alfred; Monash University
Recruiting - verified January 2012 - Condition: Spinal Cord Injury
Interventions: Device: Therastride Treadmill System; Device: FES-assisted cycling; Other: Trunk and upper and lower limb exercises; Other: Upper body strength and fitness program
Sponsors: University of Melbourne; University of Melbourne; Victorian Neurotrauma Initiative; Life Time Care and Support Authority (NSW); The University of Western Australia
Recruiting - verified August 2010 - Conditions: Diabetic Retinopathy; Macular Edema
Interventions: Drug: bevacizumab; Drug: dexamethasone
Sponsors: University of Sydney; University of Sydney; National Health and Medical Research Council, Australia
Recruiting - verified February 2012 - Condition: Osteoarthritis, Knee
Interventions: Drug: Vitamin D; Drug: Placebo
Sponsors: Menzies Research Institute Tasmania; Menzies Research Institute Tasmania; Monash University
Active, not recruiting - verified April 2012 - Condition: Delirium
Interventions: Drug: Dexmedetomidine; Drug: Saline placebo
Sponsors: Austin Health; Austin Health; Hospira Pty Ltd
Recruiting - verified May 2010 - Condition: Duchenne Muscular Dystrophy
Intervention:
Sponsors: Cooperative International Neuromuscular Research Group; Cooperative International Neuromuscular Research Group; Muscular Dystrophy Association; Children's Research Institute; Washington University, St. Louis; Royal Children's Hospital; Children's Hospital at Westmead; Centro Clinico Nemo; Carolinas Medical Center
Completed - verified October 2011 - Conditions: Infant, Premature, Diseases; Bronchopulmonary Dysplasia; Retinopathy of Prematurity; Infant, Newborn, Diseases; Infant, Very Low Birth Weight
Interventions: Procedure: Higher oxygen saturation target range (91%-95%); Procedure: Lower oxygen saturation (85%-89%)
Sponsors: University of Sydney; University of Sydney; University of Otago; University of Oxford; University of Pennsylvania; University of California, San Diego
Recruiting - verified August 2011 - Conditions: Schizoaffective and Schizophreniform Disorders; Schizophrenia
Interventions: Drug: Ondansetron; Drug: Placebo
Sponsors: Bayside Health; Bayside Health
Recruiting - verified October 2011 - Condition: Diabetic Nephropathies
Interventions: Drug: Moxonidine; Drug: Placebo
Sponsors: Baker IDI Heart and Diabetes Institute; Baker IDI Heart and Diabetes Institute
Recruiting - verified March 2010 - Condition: Spinal Cord Injury
Interventions: Device: ReJoyce Workstation; Other: Standard Care
Sponsors: University of Melbourne; University of Melbourne; Victorian Neurotrauma Initiative; Lifetime Care and Support Authority (NSW); The University of Western Australia
Recruiting - verified March 2010 - Condition: Cardiovascular Disease
Interventions: Drug: Active Clonidine; Drug: Placebo Clonidine; Drug: Active ASA; Drug: Placebo ASA
Sponsors: McMaster University; Hamilton Health Sciences Corporation; McMaster University
Recruiting - verified December 2011 - Condition: Heart Failure
Intervention:
Sponsors: Monash University; Monash University; The Alfred
Active, not recruiting - verified October 2011 - Condition: Crohn's Disease
Interventions: Procedure: endoscopy; Procedure: standard best practice post-operative care
Sponsors: University of Melbourne; University of Melbourne
Active, not recruiting - verified March 2012 - Condition: Traumatic Brain Injury
Interventions: Drug: Epoetin Alfa; Drug: Placebo, Sodium Chloride
Sponsors: Australian and New Zealand Intensive Care Research Centre; Australian and New Zealand Intensive Care Research Centre; National Health and Medical Research Council, Australia; Victorian Neurotrauma Initiative; Australian and New Zealand Intensive Care Society Clinical Trials Group; Monash University
Recruiting - verified April 2012 - Condition: Severe Traumatic Brain Injury
Interventions: Other: Hypothermia; Other: Normothermia
Sponsors: Australian and New Zealand Intensive Care Research Centre; Australian and New Zealand Intensive Care Research Centre; Australian and New Zealand Intensive Care Society Clinical Trials Group; National Health and Medical Research Council, Australia; Victorian Neurotrauma Initiative
Recruiting - verified April 2012 - Condition: Severe Sepsis
Interventions: Other: Standard Care; Other: Early Goal Directed Therapy (EGDT)
Sponsors: Monash University; Belinda Howe; Australian and New Zealand Intensive Care Society Clinical Trials Group; Australasian College for Emergency Medicine
Recruiting - verified April 2012 - Conditions: Kidney Failure, Acute; Shock
Interventions: Device: Standard polyamide high flux membrane; Device: High cut-off (super high flux) polyamide membrane
Sponsors: Austin Health; Austin Health
Completed - verified January 2012 - Conditions: Healthy; Obesity
Intervention: Drug: ghrelin
Sponsors: Baker IDI Heart and Diabetes Institute; Baker IDI Heart and Diabetes Institute
Completed - verified December 2011 - Condition: Acute Kidney Dysfunction
Interventions: Drug: Atorvastatin; Drug: Placebo
Sponsors: Austin Health; Austin Health
Recruiting - verified August 2009 - Condition: Stroke
Interventions: Drug: Tissue Plasminogen Activator (Alteplase); Drug: Placebo
Sponsors: National Stroke Research Institute, Australia; National Stroke Research Institute, Australia; Commonwealth Scientific & Industry Research Organisation; Brain Research Institute; University of Melbourne; Melbourne Health
Recruiting - verified May 2012 - Condition: Acute Kidney Injury
Interventions: Drug: Sodium Bicarbonate; Drug: Sodium Chloride
Sponsors: Austin Health; Austin Health
Recruiting - verified April 2009 - Condition: Heart Failure
Intervention: Other: NGAL kit
Sponsors: The Alfred; The Alfred; Biosite
Recruiting - verified February 2012 - Condition: Major Depressive Disorder
Interventions: Procedure: bilateral ultrabrief ECT; Procedure: bilateral standard ECT; Procedure: right-unilateral ultrabrief ECT; Procedure: right-unilateral standard ECT
Sponsors: The University of New South Wales; The University of New South Wales; Northside Clinic, Australia; The Melbourne Clinic, Australia; St George Hospital, Australia; Wandene Private Hospital, Australia
Recruiting - verified September 2011 - Conditions: Breast Neoplasms; Heart Failure
Intervention:
Sponsors: Royal Prince Alfred Hospital, Sydney, Australia; Royal Prince Alfred Hospital, Sydney, Australia
Recruiting - verified July 2011 - Condition: Central Arterial Pressure
Interventions: Drug: Ivabradine; Drug: Metoprolol; Drug: Placebo
Sponsors: Bayside Health; Bayside Health
Withdrawn - verified November 2009 - Condition: Prostate Cancer
Intervention:
Sponsors: Barwon Health; Barwon Health
Recruiting - verified August 2011 - Conditions: Liver Fibrosis; Heart Failure
Intervention: Device: FibroScan
Sponsors: Monash University; Monash University; The Alfred
Completed - verified July 2011 - Conditions: Intracerebral Hemorrhage; Stroke; Hypertension
Intervention: Other: Blood pressure management policies
Sponsors: The George Institute; The George Institute; National Health and Medical Research Council, Australia
Recruiting - verified February 2012 - Conditions: Acute Renal Failure; Sepsis; Septic Shock
Interventions: Drug: Angiotensin II; Drug: Saline placebo
Sponsors: Austin Health; Austin Health; Northern Health and Social Care Trust; Western Hospital, Australia
Recruiting - verified January 2009 - Conditions: Systemic Inflammatory Response Syndrome; Oliguria; Renal Impairment
Interventions: Drug: Sodium bicarbonate; Drug: Placebo
Sponsors: Austin Health; Austin Health
Not yet recruiting - verified July 2009 - Condition: Peripheral Arterial Disease
Intervention: Drug: Ramipril or matching placebo
Sponsors: Bayside Health; Bayside Health
Completed - verified April 2012 - Conditions: Cardiac Surgery; Cardiopulmonary Bypass
Interventions: Drug: Sodium Bicarbonate; Drug: Sodium Chloride
Sponsors: Austin Health; Austin Health
Recruiting - verified November 2009 - Condition: Heart Failure
Interventions: Drug: Urotensine II; Drug: Soluble epoxide hydrolase
Sponsors: Monash University; Monash University
Completed - verified July 2011 - Condition: Pandemic Influenza
Intervention:
Sponsors: Kirby Institute; Kirby Institute; National Health and Medical Research Council, Australia
Withdrawn - verified April 2012 - Condition: Pandemic Influenza
Intervention:
Sponsors: Kirby Institute; Kirby Institute; National Health and Medical Research Council, Australia
Withdrawn - verified April 2012 - Condition: Pandemic Influenza
Intervention:
Sponsors: Kirby Institute; Kirby Institute; National Health and Medical Research Council, Australia
Withdrawn - verified April 2012 - Condition: Heart Failure
Interventions: Drug: Spironolactone; Drug: Placebo
Sponsors: Monash University; Monash University; National Heart Foundation, Australia
Recruiting - verified March 2012 - Conditions: Female Genital Diseases; Ovarian Cancer; Cervical Cancer; Endometrial Cancer; Vulval Cancer
Intervention:
Sponsors: Queensland Centre for Gynaecological Cancer; Queensland Centre for Gynaecological Cancer; The University of Queensland; Royal Brisbane and Women's Hospital; Mater Health Services, Brisbane; Mater Private Hospital; Queensland Institute of Medical Research; Queensland University of Technology; Australia New Zealand Gynaecological Oncology Group; Cancer Australia
Active, not recruiting - verified June 2011 - Condition: Breast Cancer
Interventions: Drug: Letrozole; Drug: Letrozole
Sponsors: International Breast Cancer Study Group; International Breast Cancer Study Group
Recruiting - verified March 2012 - Condition: Cardiovascular Disease
Intervention:
Sponsors: Monash University; Monash University
Recruiting - verified March 2012 - Condition: Bronchiectasis
Intervention: Drug: Hypertonic saline 6% -
Sponsors: The Alfred; The Alfred
Completed - verified June 2011 - Conditions: Fallopian Tube Cancer; Ovarian Cancer; Primary Peritoneal Cavity Cancer
Interventions: Biological: bevacizumab; Drug: carboplatin; Drug: paclitaxel; Other: questionnaire administration; Other: study of socioeconomic and demographic variables; Procedure: quality-of-life assessment
Sponsors: National Cancer Institute (NCI); Medical Research Council
Recruiting - verified April 2012 - Condition: Lung Diseases
Interventions: Drug: Sildenafil; Drug: Placebo
Sponsors: Mercy Hospital for Women, Australia; Mercy Hospital for Women, Australia
Active, not recruiting - verified August 2011 - Condition: Rectal Cancer
Interventions: Drug: oxaliplatin; Drug: fluorouracil; Drug: leucovorin; Procedure: External beam radiotherapy
Sponsors: Peter MacCallum Cancer Centre, Australia; Peter MacCallum Cancer Centre, Australia
Completed - verified September 2011 - Condition: End Stage Kidney Disease
Intervention: Procedure: hemodialysis
Sponsors: Universitaire Ziekenhuizen Leuven; Universitaire Ziekenhuizen Leuven
Active, not recruiting - verified September 2011 - Condition: Coronary Artery Disease
Intervention:
Sponsors: Monash University; Monash University; Royal Brompton & Harefield NHS Foundation Trust; IM Medical Ltd, Melbourne
Recruiting - verified March 2012 - Condition: Heart Failure
Intervention: Behavioral: Early detection of heart failure
Sponsors: The Alfred; Henry Krum; HBA
Active, not recruiting - verified April 2012 - Condition: Prostate Cancer
Interventions: Procedure: 7800 cGy/39 fractions in 8 weeks; Procedure: 6000 cGy/20 fractions in 4 weeks
Sponsors: Ontario Clinical Oncology Group (OCOG); Ontario Clinical Oncology Group (OCOG); Canadian Institutes of Health Research (CIHR); Trans-Tasman Radiation Oncology Group (TROG)
Active, not recruiting - verified October 2011 - Conditions: Flail Chest; Ventilation
Intervention: Procedure: operative fixation of fractured ribs
Sponsors: The Alfred; The Alfred
Recruiting - verified February 2012 - Condition: Breast Cancer
Interventions: Radiation: 3D-CRT APBI; Radiation: WBI
Sponsors: Ontario Clinical Oncology Group (OCOG); Ontario Clinical Oncology Group (OCOG); Canadian Institutes of Health Research (CIHR); Canadian Breast Cancer Research Alliance
Active, not recruiting - verified July 2011 - Conditions: Tibial Fracture; Soft Tissue Injury
Intervention: Procedure: Hyperbaric Oxygenation
Sponsors: Bayside Health; Bayside Health
Recruiting - verified February 2012 - Condition: Muscular Dystrophy, Duchenne
Intervention: Drug: Pentoxifylline
Sponsors: Cooperative International Neuromuscular Research Group; Cooperative International Neuromuscular Research Group
Completed - verified October 2011 - Conditions: Cerebrovascular Accident; Diabetes; Hyperglycemia
Intervention:
Sponsors: Melbourne Health; Melbourne Health; National Health and Medical Research Council, Australia
Terminated - verified July 2011 - Conditions: Multiple Myeloma; Lymphoma
Intervention: Drug: VTP195183
Sponsors: Peter MacCallum Cancer Centre, Australia; Peter MacCallum Cancer Centre, Australia; The Leukemia and Lymphoma Society
Completed - verified May 2012 - Condition: Brain and Central Nervous System Tumors
Interventions: Drug: temozolomide; Radiation: radiation therapy
Sponsors: European Organization for Research and Treatment of Cancer - EORTC; European Organization for Research and Treatment of Cancer - EORTC; NCIC Clinical Trials Group; British Medical Research Council; Trans-Tasman Radiation Oncology Group (TROG)
Active, not recruiting - verified February 2012 - Condition: Schizophrenia
Interventions: Device: Transcranial Magnetic Stimulation; Device: sham TMS
Sponsors: The Alfred; The Alfred
Completed - verified April 2012 - Condition: Apnea of Prematurity
Intervention: Drug: Caffeine citrate injection
Sponsors: McMaster University; McMaster University; Canadian Institutes of Health Research (CIHR); National Health and Medical Research Council, Australia
Active, not recruiting - verified March 2012 - Conditions: HIV Infections; Hypersensitivity
Intervention:
Sponsors: The Alfred; The Alfred; National Health and Medical Research Council, Australia; Monash University
Withdrawn - verified January 2012 - Conditions: Urticaria; Angioedema
Intervention: Behavioral: Dietary Therapy
Sponsors: Bayside Health; Bayside Health
Not yet recruiting - verified September 2005 - Condition: HIV Infections
Intervention:
Sponsors: The Alfred; The Alfred; National Health and Medical Research Council, Australia
Completed - verified January 2012 - Condition: HIV Infections
Intervention:
Sponsors: The Alfred; The Alfred; National Health and Medical Research Council, Australia
Completed - verified January 2012 - Condition: HIV Infections
Interventions: Drug: ondansetron, ibuprofen, paracetamol; Drug: Ondansetron, ibuprofen, paracetamol; Drug: metoclopramide, ibuprofen, paracetamol; Drug: Metoclopramide, codeine phosphate, ibuprofen, paracetamol
Sponsors: Kirby Institute; Kirby Institute; The University of New South Wales
Terminated - verified April 2012 - Condition: Brain and Central Nervous System Tumors
Interventions: Biological: filgrastim; Drug: cisplatin; Drug: cyclophosphamide; Drug: vincristine sulfate; Procedure: autologous hematopoietic stem cell transplantation; Radiation: radiation therapy
Sponsors: St. Jude Children's Research Hospital; St. Jude Children's Research Hospital
Recruiting - verified January 2012 - Condition: Breast Cancer
Interventions: Procedure: axillary lymph node dissection; Procedure: No axillary lymph node dissection
Sponsors: International Breast Cancer Study Group; International Breast Cancer Study Group
Active, not recruiting - verified February 2012 - Condition: Pancreatic Cancer
Interventions: Drug: erlotinib hydrochloride; Drug: gemcitabine hydrochloride
Sponsors: NCIC Clinical Trials Group; NCIC Clinical Trials Group
Completed - verified September 2011 - Condition: Breast Cancer
Interventions: Drug: CAF regimen; Drug: CMF regimen; Drug: cyclophosphamide; Drug: doxorubicin hydrochloride; Drug: epirubicin hydrochloride; Drug: fluorouracil; Drug: methotrexate; Procedure: adjuvant therapy
Sponsors: National Cancer Institute (NCI); International Breast Cancer Study Group
Recruiting - verified September 2008 - Condition: Melanoma (Skin)
Interventions: Biological: pegylated interferon alfa; Procedure: adjuvant therapy
Sponsors: National Cancer Institute (NCI); European Organization for Research and Treatment of Cancer - EORTC
Active, not recruiting - verified October 2000 - Condition: Lung Cancer
Interventions: Biological: BCG vaccine; Biological: monoclonal antibody BEC2
Sponsors: European Organization for Research and Treatment of Cancer - EORTC; European Organization for Research and Treatment of Cancer - EORTC
Completed - verified March 2012 - Condition: Endometrial Cancer
Intervention: Radiation: radiation therapy
Sponsors: NCIC Clinical Trials Group; NCIC Clinical Trials Group
Completed - verified April 2012
 |
Join Clinical Trials by University in Victoria, Australia |
